bpc 157 clinical trial human randomized The Stable Gastric Pentadecapeptide Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity Should YOU Be Taking BPC-157
Description
It is not about whether peptide therapeutics as a class are interesting
& Mrsny, R
Dose: 0.51 mg per day , subcutaneous Frequency: 35 times weekly Cycle: 8 weeks on / 4 weeks off , repeated indefinitely Stack: commonly run alongside NAD+ infusions and CJC-1295 / Ipamorelin for full anti-ageing coverage
While not ideal, it may not have ruined the entire vial
